

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.04857320 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.04857320 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.84270996 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.84270996 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.93665937 |
| 6 | negative regulation of complement activation (GO:0045916) | 4.80367256 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.44686621 |
| 8 | glyoxylate metabolic process (GO:0046487) | 4.43689353 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 4.36063925 |
| 10 | regulation of fibrinolysis (GO:0051917) | 4.33481849 |
| 11 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.31090662 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 4.26235188 |
| 13 | bile acid biosynthetic process (GO:0006699) | 4.24868209 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.17541834 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.17541834 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.17541834 |
| 17 | plasma lipoprotein particle assembly (GO:0034377) | 4.14563469 |
| 18 | desmosome organization (GO:0002934) | 4.13803115 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.12993555 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.10736828 |
| 21 | protein carboxylation (GO:0018214) | 4.10736828 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.02777785 |
| 23 | kynurenine metabolic process (GO:0070189) | 4.00772089 |
| 24 | tryptophan metabolic process (GO:0006568) | 3.96964447 |
| 25 | triglyceride homeostasis (GO:0070328) | 3.96642799 |
| 26 | acylglycerol homeostasis (GO:0055090) | 3.96642799 |
| 27 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.94108251 |
| 28 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.94108251 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 3.91180293 |
| 30 | low-density lipoprotein particle remodeling (GO:0034374) | 3.89305106 |
| 31 | regulation of complement activation (GO:0030449) | 3.86429469 |
| 32 | endothelium development (GO:0003158) | 3.86172875 |
| 33 | epoxygenase P450 pathway (GO:0019373) | 3.82750183 |
| 34 | reverse cholesterol transport (GO:0043691) | 3.78520413 |
| 35 | fibrinolysis (GO:0042730) | 3.77142370 |
| 36 | complement activation, alternative pathway (GO:0006957) | 3.76230754 |
| 37 | cysteine metabolic process (GO:0006534) | 3.72867759 |
| 38 | protein-lipid complex assembly (GO:0065005) | 3.71773025 |
| 39 | plasma lipoprotein particle organization (GO:0071827) | 3.69358163 |
| 40 | urea metabolic process (GO:0019627) | 3.68631177 |
| 41 | urea cycle (GO:0000050) | 3.68631177 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 3.66314338 |
| 43 | complement activation, classical pathway (GO:0006958) | 3.64031836 |
| 44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.62881146 |
| 45 | bile acid and bile salt transport (GO:0015721) | 3.62607776 |
| 46 | bile acid metabolic process (GO:0008206) | 3.62319515 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 3.60022475 |
| 48 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.59718342 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 3.59533272 |
| 50 | phospholipid efflux (GO:0033700) | 3.57874300 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 3.57423091 |
| 52 | negative regulation of humoral immune response (GO:0002921) | 3.54604780 |
| 53 | cellular glucuronidation (GO:0052695) | 3.54212770 |
| 54 | positive regulation of extracellular matrix organization (GO:1903055) | 3.53684230 |
| 55 | alpha-linolenic acid metabolic process (GO:0036109) | 3.51333619 |
| 56 | intestinal absorption (GO:0050892) | 3.50452692 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.49546208 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.49546208 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.49546208 |
| 60 | protein-lipid complex subunit organization (GO:0071825) | 3.48757636 |
| 61 | positive regulation of respiratory burst (GO:0060267) | 3.46795553 |
| 62 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44405919 |
| 63 | negative regulation of lipase activity (GO:0060192) | 3.44352960 |
| 64 | arginine metabolic process (GO:0006525) | 3.43187007 |
| 65 | hemidesmosome assembly (GO:0031581) | 3.42606274 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 3.40035809 |
| 67 | homocysteine metabolic process (GO:0050667) | 3.38406864 |
| 68 | negative regulation of hemostasis (GO:1900047) | 3.37897071 |
| 69 | negative regulation of blood coagulation (GO:0030195) | 3.37897071 |
| 70 | lymph vessel development (GO:0001945) | 3.37209496 |
| 71 | regulation of bile acid biosynthetic process (GO:0070857) | 3.36335887 |
| 72 | blood coagulation, intrinsic pathway (GO:0007597) | 3.33755939 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 3.33298371 |
| 74 | tyrosine metabolic process (GO:0006570) | 3.33259864 |
| 75 | cholesterol homeostasis (GO:0042632) | 3.32275076 |
| 76 | regulation of cholesterol homeostasis (GO:2000188) | 3.31887369 |
| 77 | complement activation (GO:0006956) | 3.29875092 |
| 78 | alpha-amino acid catabolic process (GO:1901606) | 3.29697050 |
| 79 | sterol homeostasis (GO:0055092) | 3.25941513 |
| 80 | drug catabolic process (GO:0042737) | 3.24414165 |
| 81 | negative regulation of protein activation cascade (GO:2000258) | 3.22961443 |
| 82 | regulation of apoptotic cell clearance (GO:2000425) | 3.22146747 |
| 83 | exocrine pancreas development (GO:0031017) | 3.21133042 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.18603489 |
| 85 | glucuronate metabolic process (GO:0019585) | 3.18603489 |
| 86 | heme transport (GO:0015886) | 3.18198904 |
| 87 | negative regulation of coagulation (GO:0050819) | 3.15291547 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 3.15185892 |
| 89 | amine catabolic process (GO:0009310) | 3.15185892 |
| 90 | regulation of humoral immune response (GO:0002920) | 3.14605073 |
| 91 | cholesterol efflux (GO:0033344) | 3.13245055 |
| 92 | regulation of respiratory burst (GO:0060263) | 3.12787077 |
| 93 | negative regulation of wound healing (GO:0061045) | 3.12024995 |
| 94 | ethanol oxidation (GO:0006069) | 3.10767636 |
| 95 | Rap protein signal transduction (GO:0032486) | 3.10635836 |
| 96 | lysine metabolic process (GO:0006553) | 3.09519595 |
| 97 | lysine catabolic process (GO:0006554) | 3.09519595 |
| 98 | transcytosis (GO:0045056) | 3.08224874 |
| 99 | cellular ketone body metabolic process (GO:0046950) | 3.07803645 |
| 100 | flavonoid metabolic process (GO:0009812) | 3.07673430 |
| 101 | opsonization (GO:0008228) | 3.06670100 |
| 102 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.06409954 |
| 103 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.04407867 |
| 104 | negative regulation of sterol transport (GO:0032372) | 3.03641406 |
| 105 | negative regulation of cholesterol transport (GO:0032375) | 3.03641406 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 3.02486340 |
| 107 | proline metabolic process (GO:0006560) | 3.01104067 |
| 108 | protein activation cascade (GO:0072376) | 2.99908737 |
| 109 | surfactant homeostasis (GO:0043129) | 2.99706500 |
| 110 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.99479148 |
| 111 | positive regulation of steroid metabolic process (GO:0045940) | 2.99279779 |
| 112 | primary alcohol catabolic process (GO:0034310) | 2.96559351 |
| 113 | drug transmembrane transport (GO:0006855) | 2.96165853 |
| 114 | acute inflammatory response (GO:0002526) | 2.94528260 |
| 115 | regulation of plasminogen activation (GO:0010755) | 2.92226763 |
| 116 | aldehyde catabolic process (GO:0046185) | 2.92128733 |
| 117 | transepithelial transport (GO:0070633) | 2.91042107 |
| 118 | ethanol metabolic process (GO:0006067) | 2.90900218 |
| 119 | carnitine metabolic process (GO:0009437) | 2.89987207 |
| 120 | intestinal cholesterol absorption (GO:0030299) | 2.89471552 |
| 121 | fatty acid elongation (GO:0030497) | 2.88339449 |
| 122 | exogenous drug catabolic process (GO:0042738) | 2.87979034 |
| 123 | coenzyme catabolic process (GO:0009109) | 2.87449593 |
| 124 | acute-phase response (GO:0006953) | 2.87282522 |
| 125 | benzene-containing compound metabolic process (GO:0042537) | 2.85469960 |
| 126 | basement membrane organization (GO:0071711) | 2.85066212 |
| 127 | lipoprotein metabolic process (GO:0042157) | 2.84420573 |
| 128 | glycine metabolic process (GO:0006544) | 2.83532019 |
| 129 | indolalkylamine metabolic process (GO:0006586) | 2.82400999 |
| 130 | urate metabolic process (GO:0046415) | 2.82051902 |
| 131 | drug metabolic process (GO:0017144) | 2.81963659 |
| 132 | fatty acid beta-oxidation (GO:0006635) | 2.80959664 |
| 133 | gap junction assembly (GO:0016264) | 2.79502950 |
| 134 | L-ascorbic acid metabolic process (GO:0019852) | 2.79078886 |
| 135 | multicellular organismal water homeostasis (GO:0050891) | 2.76269869 |
| 136 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.73620201 |
| 137 | regulation of cholesterol metabolic process (GO:0090181) | 2.73366956 |
| 138 | sterol transport (GO:0015918) | 2.68132256 |
| 139 | cholesterol transport (GO:0030301) | 2.68132256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.68971869 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.53734637 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48569866 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.77684189 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.67906791 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.42906030 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.33512461 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.11904055 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.50782658 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.26748776 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.81833779 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.80616801 |
| 13 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.57705044 |
| 14 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52902632 |
| 15 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.43521925 |
| 16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.40833168 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.19306878 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16234677 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.91829139 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.90599812 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83877704 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.82869162 |
| 23 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79241102 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.76791790 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75841967 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73990991 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67940825 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58610897 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47745345 |
| 30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.39738573 |
| 31 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35457762 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33365466 |
| 33 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31598177 |
| 34 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30985208 |
| 35 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30089754 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29587682 |
| 37 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.28652012 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27949789 |
| 39 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26842809 |
| 40 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26435453 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26367577 |
| 42 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24907195 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23961067 |
| 44 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23212123 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20869782 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18188509 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17503539 |
| 48 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13545630 |
| 49 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13545630 |
| 50 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12203054 |
| 51 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.10210105 |
| 52 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09590934 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08233058 |
| 54 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.06647219 |
| 55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.04874879 |
| 56 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.03845387 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03694450 |
| 58 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03128322 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02626678 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00497916 |
| 61 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99171874 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98778430 |
| 63 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.98582035 |
| 64 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96128932 |
| 65 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95703692 |
| 66 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94884573 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93936765 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93406171 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89399393 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88325225 |
| 71 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87681076 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87338987 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87338987 |
| 74 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86728528 |
| 75 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86486128 |
| 76 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85210283 |
| 77 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84946802 |
| 78 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84337882 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83792128 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83792128 |
| 81 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82918257 |
| 82 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.81898582 |
| 83 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.81898582 |
| 84 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.81898582 |
| 85 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.80971983 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79803496 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79505421 |
| 88 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79008859 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77965906 |
| 90 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77949812 |
| 91 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76381405 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76002322 |
| 93 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74576006 |
| 94 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.74209666 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73807552 |
| 96 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.71697451 |
| 97 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.71601855 |
| 98 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71409134 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71148932 |
| 100 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71031570 |
| 101 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.71006221 |
| 102 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70291434 |
| 103 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69824573 |
| 104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.69573071 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68543579 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.68208642 |
| 107 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.67889512 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.66646455 |
| 109 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.65824132 |
| 110 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65389767 |
| 111 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.65274554 |
| 112 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.64389914 |
| 113 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.63934749 |
| 114 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63547576 |
| 115 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.63305104 |
| 116 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.63241440 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.63066302 |
| 118 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.62289362 |
| 119 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.61845088 |
| 120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.60913250 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60562708 |
| 122 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60371040 |
| 123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60005526 |
| 124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.59596881 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59284074 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.59228362 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58986279 |
| 128 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.58648066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.81622184 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.48840078 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.66212104 |
| 4 | MP0005365_abnormal_bile_salt | 3.96032585 |
| 5 | MP0005670_abnormal_white_adipose | 3.79823879 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.64606709 |
| 7 | MP0010368_abnormal_lymphatic_system | 3.63662632 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.02019843 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.60064173 |
| 10 | MP0003252_abnormal_bile_duct | 2.59728339 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.49031313 |
| 12 | MP0001879_abnormal_lymphatic_vessel | 2.40071231 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.37545123 |
| 14 | MP0005083_abnormal_biliary_tract | 2.36893308 |
| 15 | MP0002796_impaired_skin_barrier | 2.36633298 |
| 16 | MP0009840_abnormal_foam_cell | 2.27068900 |
| 17 | MP0009379_abnormal_foot_pigmentation | 2.10086092 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.06236929 |
| 19 | MP0004272_abnormal_basement_membrane | 2.01536700 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 2.00809154 |
| 21 | MP0005332_abnormal_amino_acid | 1.95794973 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.93525007 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.91854148 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.82461320 |
| 25 | MP0005451_abnormal_body_composition | 1.81868345 |
| 26 | MP0003195_calcinosis | 1.79046984 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.70326181 |
| 28 | MP0002254_reproductive_system_inflammat | 1.67858853 |
| 29 | MP0000566_synostosis | 1.67798918 |
| 30 | MP0009697_abnormal_copulation | 1.61321252 |
| 31 | MP0004381_abnormal_hair_follicle | 1.53017491 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.43242609 |
| 33 | MP0005409_darkened_coat_color | 1.35067498 |
| 34 | MP0000003_abnormal_adipose_tissue | 1.33951972 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.33147910 |
| 36 | MP0002060_abnormal_skin_morphology | 1.31787380 |
| 37 | MP0005275_abnormal_skin_tensile | 1.31395980 |
| 38 | MP0002098_abnormal_vibrissa_morphology | 1.31052612 |
| 39 | MP0000383_abnormal_hair_follicle | 1.30915418 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.30208430 |
| 41 | MP0003724_increased_susceptibility_to | 1.28474662 |
| 42 | MP0003941_abnormal_skin_development | 1.28451129 |
| 43 | MP0005501_abnormal_skin_physiology | 1.28389771 |
| 44 | MP0003868_abnormal_feces_composition | 1.28201251 |
| 45 | MP0000609_abnormal_liver_physiology | 1.27293188 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.24473019 |
| 47 | MP0000762_abnormal_tongue_morphology | 1.19652345 |
| 48 | MP0003123_paternal_imprinting | 1.18907771 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.18801083 |
| 50 | MP0006054_spinal_hemorrhage | 1.17877632 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.17813239 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.17358192 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.17315301 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.15609241 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.15371166 |
| 56 | MP0005408_hypopigmentation | 1.14153772 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.13961205 |
| 58 | MP0008004_abnormal_stomach_pH | 1.13910209 |
| 59 | MP0003011_delayed_dark_adaptation | 1.08854272 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.08235681 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.08024981 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.02555394 |
| 63 | MP0001764_abnormal_homeostasis | 1.01881819 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.01674428 |
| 65 | MP0000579_abnormal_nail_morphology | 1.00204269 |
| 66 | MP0001216_abnormal_epidermal_layer | 0.99170645 |
| 67 | MP0000647_abnormal_sebaceous_gland | 0.92466810 |
| 68 | MP0001851_eye_inflammation | 0.92041108 |
| 69 | MP0003828_pulmonary_edema | 0.91726148 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.90527832 |
| 71 | MP0004043_abnormal_pH_regulation | 0.88428291 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.88250954 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.88136794 |
| 74 | MP0006138_congestive_heart_failure | 0.86898240 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.86088425 |
| 76 | MP0005023_abnormal_wound_healing | 0.85722885 |
| 77 | MP0010771_integument_phenotype | 0.85024782 |
| 78 | MP0000377_abnormal_hair_follicle | 0.84746092 |
| 79 | MP0000537_abnormal_urethra_morphology | 0.84539961 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 0.83833865 |
| 81 | MP0000678_abnormal_parathyroid_gland | 0.83174452 |
| 82 | MP0003943_abnormal_hepatobiliary_system | 0.82550327 |
| 83 | MP0001542_abnormal_bone_strength | 0.79719642 |
| 84 | MP0005410_abnormal_fertilization | 0.79056503 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.78367553 |
| 86 | MP0003186_abnormal_redox_activity | 0.78059834 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.77576279 |
| 88 | MP0001873_stomach_inflammation | 0.77332757 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.75834653 |
| 90 | MP0000538_abnormal_urinary_bladder | 0.75163785 |
| 91 | MP0002282_abnormal_trachea_morphology | 0.74367463 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.73953976 |
| 93 | MP0000427_abnormal_hair_cycle | 0.72628254 |
| 94 | MP0003315_abnormal_perineum_morphology | 0.72121458 |
| 95 | MP0004084_abnormal_cardiac_muscle | 0.71370680 |
| 96 | MP0005395_other_phenotype | 0.70375859 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.70100009 |
| 98 | MP0000249_abnormal_blood_vessel | 0.68889416 |
| 99 | MP0000598_abnormal_liver_morphology | 0.68797552 |
| 100 | MP0005647_abnormal_sex_gland | 0.68685722 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.67716793 |
| 102 | MP0001243_abnormal_dermal_layer | 0.67581584 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.67539901 |
| 104 | MP0002168_other_aberrant_phenotype | 0.67471462 |
| 105 | MP0000613_abnormal_salivary_gland | 0.67349364 |
| 106 | MP0003878_abnormal_ear_physiology | 0.67306846 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.67306846 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.67257342 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66216073 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.65388723 |
| 111 | MP0005330_cardiomyopathy | 0.65357161 |
| 112 | MP0003718_maternal_effect | 0.65028895 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.64998113 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 0.64892179 |
| 115 | MP0002132_abnormal_respiratory_system | 0.64842674 |
| 116 | MP0000627_abnormal_mammary_gland | 0.64105926 |
| 117 | MP0005165_increased_susceptibility_to | 0.63734919 |
| 118 | MP0001756_abnormal_urination | 0.63457474 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.63159032 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.62956152 |
| 121 | MP0009764_decreased_sensitivity_to | 0.62612235 |
| 122 | MP0005334_abnormal_fat_pad | 0.62357106 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.61579978 |
| 124 | MP0005164_abnormal_response_to | 0.60019469 |
| 125 | MP0002896_abnormal_bone_mineralization | 0.59464990 |
| 126 | MP0009763_increased_sensitivity_to | 0.59423785 |
| 127 | MP0005385_cardiovascular_system_phenoty | 0.59354888 |
| 128 | MP0001544_abnormal_cardiovascular_syste | 0.59354888 |
| 129 | MP0001270_distended_abdomen | 0.58841136 |
| 130 | MP0004883_abnormal_blood_vessel | 0.58762472 |
| 131 | MP0001614_abnormal_blood_vessel | 0.58347397 |
| 132 | MP0000163_abnormal_cartilage_morphology | 0.57916207 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.55661343 |
| 134 | MP0009931_abnormal_skin_appearance | 0.55528859 |
| 135 | MP0005508_abnormal_skeleton_morphology | 0.54506202 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.53782657 |
| 137 | MP0000462_abnormal_digestive_system | 0.53707580 |
| 138 | MP0003953_abnormal_hormone_level | 0.50854830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.89589008 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.79510182 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.74198107 |
| 4 | Glomerulonephritis (HP:0000099) | 4.83652766 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.77352724 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.75341438 |
| 7 | Xanthomatosis (HP:0000991) | 4.68133457 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.45151020 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.21999146 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.66289034 |
| 11 | Hypolipoproteinemia (HP:0010981) | 3.47578844 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.43778352 |
| 13 | Complement deficiency (HP:0004431) | 3.43069742 |
| 14 | Right ventricular cardiomyopathy (HP:0011663) | 3.39984927 |
| 15 | Hemorrhage of the eye (HP:0011885) | 3.38475445 |
| 16 | Fat malabsorption (HP:0002630) | 3.34066561 |
| 17 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.33158137 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.31060653 |
| 19 | Joint hemorrhage (HP:0005261) | 3.30830012 |
| 20 | Hypoglycemic seizures (HP:0002173) | 3.25085277 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.24943145 |
| 22 | Hyperammonemia (HP:0001987) | 3.24806528 |
| 23 | Nephritis (HP:0000123) | 3.14740672 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14733904 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.14013126 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.04532394 |
| 27 | Hyperglycinemia (HP:0002154) | 2.98429916 |
| 28 | Hyperglycinuria (HP:0003108) | 2.96811140 |
| 29 | Abnormal tarsal ossification (HP:0008369) | 2.91767521 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.88855878 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88855878 |
| 32 | Mitral stenosis (HP:0001718) | 2.86524253 |
| 33 | Epidermoid cyst (HP:0200040) | 2.85991592 |
| 34 | Vascular calcification (HP:0004934) | 2.81861940 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 2.81511283 |
| 36 | Hypoglycemic coma (HP:0001325) | 2.79233584 |
| 37 | Growth hormone excess (HP:0000845) | 2.77451804 |
| 38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.71584455 |
| 39 | Ketosis (HP:0001946) | 2.70683929 |
| 40 | Malnutrition (HP:0004395) | 2.69078104 |
| 41 | Fragile nails (HP:0001808) | 2.69075607 |
| 42 | Onycholysis (HP:0001806) | 2.65409036 |
| 43 | Follicular hyperkeratosis (HP:0007502) | 2.63750708 |
| 44 | Esophageal varix (HP:0002040) | 2.63655048 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.63063239 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.60729000 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.59835940 |
| 48 | Steatorrhea (HP:0002570) | 2.57801128 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.54524540 |
| 50 | Abnormality of the nasal septum (HP:0000419) | 2.54196991 |
| 51 | Abnormality of complement system (HP:0005339) | 2.54111237 |
| 52 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.53337515 |
| 53 | Spontaneous abortion (HP:0005268) | 2.51774311 |
| 54 | Gout (HP:0001997) | 2.47581247 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.47317392 |
| 56 | Vitreoretinal degeneration (HP:0000655) | 2.46105525 |
| 57 | Ileus (HP:0002595) | 2.46005306 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.37659687 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37659687 |
| 60 | Symptomatic seizures (HP:0011145) | 2.37579544 |
| 61 | Nonimmune hydrops fetalis (HP:0001790) | 2.37336371 |
| 62 | Amyloidosis (HP:0011034) | 2.33380056 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.30969311 |
| 64 | Abnormal hemoglobin (HP:0011902) | 2.29891750 |
| 65 | Enlarged penis (HP:0000040) | 2.28253426 |
| 66 | Hypotrichosis (HP:0001006) | 2.28114517 |
| 67 | Advanced eruption of teeth (HP:0006288) | 2.27932185 |
| 68 | Abdominal distention (HP:0003270) | 2.24400283 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.22652813 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.22216671 |
| 71 | Polycythemia (HP:0001901) | 2.20611487 |
| 72 | Pigmentary retinal degeneration (HP:0001146) | 2.20537824 |
| 73 | Widely patent fontanelles and sutures (HP:0004492) | 2.15303060 |
| 74 | Protuberant abdomen (HP:0001538) | 2.14391695 |
| 75 | Sparse eyelashes (HP:0000653) | 2.14390102 |
| 76 | Plantar hyperkeratosis (HP:0007556) | 2.12494279 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.12281407 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.12281407 |
| 79 | Lethargy (HP:0001254) | 2.11382189 |
| 80 | Woolly hair (HP:0002224) | 2.11296682 |
| 81 | Parakeratosis (HP:0001036) | 2.11002682 |
| 82 | Thick nail (HP:0001805) | 2.09955316 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.09657142 |
| 84 | Rickets (HP:0002748) | 2.09532006 |
| 85 | Hyporeflexia of lower limbs (HP:0002600) | 2.07653377 |
| 86 | Menorrhagia (HP:0000132) | 2.06229722 |
| 87 | Facial shape deformation (HP:0011334) | 2.05606799 |
| 88 | Potter facies (HP:0002009) | 2.05606799 |
| 89 | Ventricular tachycardia (HP:0004756) | 2.03784463 |
| 90 | Epiphyseal dysplasia (HP:0002656) | 2.02558394 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.00991663 |
| 92 | Metabolic acidosis (HP:0001942) | 2.00547052 |
| 93 | Hypophosphatemic rickets (HP:0004912) | 2.00508228 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98842374 |
| 95 | Myocardial infarction (HP:0001658) | 1.97451400 |
| 96 | Flat acetabular roof (HP:0003180) | 1.96990226 |
| 97 | Lip pit (HP:0100267) | 1.95950350 |
| 98 | Milia (HP:0001056) | 1.95062413 |
| 99 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.94595701 |
| 100 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.94595701 |
| 101 | Elfin facies (HP:0004428) | 1.94571300 |
| 102 | Respiratory distress (HP:0002098) | 1.93474758 |
| 103 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.93211147 |
| 104 | Alopecia of scalp (HP:0002293) | 1.92866138 |
| 105 | Abnormality of the ischium (HP:0003174) | 1.92460446 |
| 106 | Abnormality of serum amino acid levels (HP:0003112) | 1.92262154 |
| 107 | Abnormality of carpal bone ossification (HP:0006257) | 1.91451462 |
| 108 | Cerebral edema (HP:0002181) | 1.91023440 |
| 109 | Pili torti (HP:0003777) | 1.90691395 |
| 110 | Abnormality of glycolysis (HP:0004366) | 1.89669661 |
| 111 | Abnormal foot bone ossification (HP:0010675) | 1.88405686 |
| 112 | Cerebral hemorrhage (HP:0001342) | 1.86957911 |
| 113 | Abnormal hair laboratory examination (HP:0003328) | 1.86949350 |
| 114 | Hyperglycemia (HP:0003074) | 1.85450032 |
| 115 | Ketoacidosis (HP:0001993) | 1.85006239 |
| 116 | Spastic paraparesis (HP:0002313) | 1.84532030 |
| 117 | Increased serum pyruvate (HP:0003542) | 1.83440677 |
| 118 | Glomerulosclerosis (HP:0000096) | 1.80061527 |
| 119 | Bronchomalacia (HP:0002780) | 1.78945085 |
| 120 | Enlarged kidneys (HP:0000105) | 1.78426583 |
| 121 | Acanthosis nigricans (HP:0000956) | 1.78418117 |
| 122 | Hypoplastic ischia (HP:0003175) | 1.77487166 |
| 123 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.77212837 |
| 124 | Cupped ribs (HP:0000887) | 1.77139479 |
| 125 | Delayed epiphyseal ossification (HP:0002663) | 1.76442966 |
| 126 | Vacuolated lymphocytes (HP:0001922) | 1.76247013 |
| 127 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.76145210 |
| 128 | Abnormality of dental color (HP:0011073) | 1.75973470 |
| 129 | Congenital, generalized hypertrichosis (HP:0004540) | 1.74728177 |
| 130 | Abnormal gallbladder physiology (HP:0012438) | 1.74465167 |
| 131 | Cholecystitis (HP:0001082) | 1.74465167 |
| 132 | Glycosuria (HP:0003076) | 1.73647102 |
| 133 | Abnormality of urine glucose concentration (HP:0011016) | 1.73647102 |
| 134 | Increased purine levels (HP:0004368) | 1.73564747 |
| 135 | Hyperuricemia (HP:0002149) | 1.73564747 |
| 136 | Bifid scrotum (HP:0000048) | 1.73524447 |
| 137 | Alkalosis (HP:0001948) | 1.73094619 |
| 138 | Focal segmental glomerulosclerosis (HP:0000097) | 1.72786403 |
| 139 | Broad metatarsal (HP:0001783) | 1.71681287 |
| 140 | Pancreatitis (HP:0001733) | 1.71196995 |
| 141 | Proximal tubulopathy (HP:0000114) | 1.70131960 |
| 142 | Arterial tortuosity (HP:0005116) | 1.69662084 |
| 143 | Back pain (HP:0003418) | 1.67737939 |
| 144 | Irregular epiphyses (HP:0010582) | 1.67342592 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.67100688 |
| 146 | Purpura (HP:0000979) | 1.66067944 |
| 147 | Long foot (HP:0001833) | 1.65794681 |
| 148 | Abnormality of the gastric mucosa (HP:0004295) | 1.65772704 |
| 149 | Seborrheic dermatitis (HP:0001051) | 1.65661812 |
| 150 | Skin nodule (HP:0200036) | 1.65330521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.93275922 |
| 2 | KDR | 4.25837837 |
| 3 | ERN1 | 3.28090351 |
| 4 | BCKDK | 3.25041797 |
| 5 | EPHB2 | 2.51831719 |
| 6 | MAP3K3 | 2.43489136 |
| 7 | MST1R | 2.40700747 |
| 8 | TGFBR2 | 2.35540640 |
| 9 | FGFR4 | 2.35133831 |
| 10 | BRSK2 | 2.18259921 |
| 11 | EPHA2 | 2.05678536 |
| 12 | MAP3K12 | 2.00775167 |
| 13 | EPHB1 | 1.98428262 |
| 14 | GRK1 | 1.92809503 |
| 15 | MET | 1.90959236 |
| 16 | TGFBR1 | 1.89507953 |
| 17 | MYLK | 1.83964981 |
| 18 | STK38L | 1.78811796 |
| 19 | FER | 1.76000684 |
| 20 | BCR | 1.69020389 |
| 21 | LATS1 | 1.68009671 |
| 22 | STK24 | 1.59278158 |
| 23 | MAP2K6 | 1.49444108 |
| 24 | PRKG2 | 1.49417777 |
| 25 | PIK3CA | 1.40942409 |
| 26 | MAPK15 | 1.40888007 |
| 27 | MAP2K2 | 1.37839261 |
| 28 | STK39 | 1.36956886 |
| 29 | MST4 | 1.34985014 |
| 30 | SIK1 | 1.31365975 |
| 31 | NUAK1 | 1.27897030 |
| 32 | NEK9 | 1.24646447 |
| 33 | MUSK | 1.19751295 |
| 34 | NME1 | 1.18610218 |
| 35 | ERBB4 | 1.17992032 |
| 36 | MAP2K3 | 1.14345678 |
| 37 | PTK6 | 1.12525798 |
| 38 | WEE1 | 1.11617360 |
| 39 | MAP3K11 | 1.01925494 |
| 40 | OBSCN | 1.01504596 |
| 41 | WNK4 | 0.93832391 |
| 42 | EPHA3 | 0.93673544 |
| 43 | FGFR3 | 0.92064677 |
| 44 | TRPM7 | 0.91918857 |
| 45 | SIK3 | 0.90373345 |
| 46 | LMTK2 | 0.90142673 |
| 47 | PRKD1 | 0.88796587 |
| 48 | RIPK1 | 0.88611783 |
| 49 | STK38 | 0.88031548 |
| 50 | PTK2 | 0.87898293 |
| 51 | FRK | 0.87246393 |
| 52 | ICK | 0.83584782 |
| 53 | PRKCI | 0.82427750 |
| 54 | PAK4 | 0.82392981 |
| 55 | MAPKAPK3 | 0.81943998 |
| 56 | MAP2K1 | 0.80901892 |
| 57 | IRAK3 | 0.80803975 |
| 58 | AKT3 | 0.80042383 |
| 59 | OXSR1 | 0.77398800 |
| 60 | PTK2B | 0.77260256 |
| 61 | RPS6KB2 | 0.77214367 |
| 62 | LRRK2 | 0.76597285 |
| 63 | MAP3K2 | 0.76550867 |
| 64 | MAPK7 | 0.75305644 |
| 65 | PIK3CG | 0.73651066 |
| 66 | PDK2 | 0.72478067 |
| 67 | MAP3K7 | 0.71422822 |
| 68 | PKN2 | 0.70832231 |
| 69 | MAP3K14 | 0.70795363 |
| 70 | GSK3A | 0.69684798 |
| 71 | MAPK12 | 0.68020576 |
| 72 | NME2 | 0.65787072 |
| 73 | MAPK11 | 0.65131972 |
| 74 | FGFR1 | 0.64635337 |
| 75 | BRSK1 | 0.64038656 |
| 76 | LIMK1 | 0.63863152 |
| 77 | MAP3K1 | 0.62441479 |
| 78 | FGFR2 | 0.62269096 |
| 79 | STK3 | 0.62107946 |
| 80 | PBK | 0.61445776 |
| 81 | PINK1 | 0.61175113 |
| 82 | TAOK3 | 0.60843271 |
| 83 | DYRK1B | 0.60692595 |
| 84 | CAMK2G | 0.58716985 |
| 85 | NEK6 | 0.58473191 |
| 86 | CSNK1G1 | 0.58232403 |
| 87 | FLT3 | 0.57568080 |
| 88 | CSNK1A1L | 0.57037227 |
| 89 | INSRR | 0.56318366 |
| 90 | IKBKB | 0.56064995 |
| 91 | ILK | 0.55370975 |
| 92 | LATS2 | 0.53497641 |
| 93 | EIF2AK1 | 0.52753864 |
| 94 | PKN1 | 0.50256210 |
| 95 | CSNK1G2 | 0.49718567 |
| 96 | PRKAA2 | 0.49662331 |
| 97 | BMPR1B | 0.49127749 |
| 98 | CSNK1G3 | 0.48444928 |
| 99 | ERBB2 | 0.46966158 |
| 100 | TBK1 | 0.46798798 |
| 101 | PIM2 | 0.46472527 |
| 102 | CHUK | 0.46249762 |
| 103 | SMG1 | 0.45860902 |
| 104 | TRIB3 | 0.45533996 |
| 105 | MAPK4 | 0.44093301 |
| 106 | ABL2 | 0.43681999 |
| 107 | EEF2K | 0.42849801 |
| 108 | TESK1 | 0.41079097 |
| 109 | PRKCE | 0.39729200 |
| 110 | MTOR | 0.39459070 |
| 111 | DDR2 | 0.39402439 |
| 112 | PDGFRA | 0.37948049 |
| 113 | MAP4K2 | 0.37427302 |
| 114 | PRKAA1 | 0.36989696 |
| 115 | ROCK1 | 0.35248789 |
| 116 | CDK12 | 0.35099189 |
| 117 | RET | 0.33505011 |
| 118 | AKT2 | 0.33494380 |
| 119 | PDPK1 | 0.32683936 |
| 120 | TYK2 | 0.32058499 |
| 121 | EIF2AK3 | 0.31715806 |
| 122 | PRKD2 | 0.31207605 |
| 123 | IKBKE | 0.31020703 |
| 124 | ZAK | 0.30010099 |
| 125 | MAPKAPK5 | 0.29543263 |
| 126 | IGF1R | 0.27710131 |
| 127 | DAPK1 | 0.27556838 |
| 128 | PAK3 | 0.25036992 |
| 129 | CAMK2D | 0.24889097 |
| 130 | JAK2 | 0.24851980 |
| 131 | STK10 | 0.23392316 |
| 132 | NTRK1 | 0.22622921 |
| 133 | MAPKAPK2 | 0.20225826 |
| 134 | YES1 | 0.19436604 |
| 135 | SRC | 0.19392653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.87489308 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.99707713 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84598762 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55190707 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52630293 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.52160559 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44927922 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40734142 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.39949130 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34707145 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33595901 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30571066 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.27424318 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.24486796 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.13131393 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.11337390 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.08378018 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02534268 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00637304 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.96683311 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.87998126 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.84134458 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83160233 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.82327626 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81652701 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77945002 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71579967 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66873253 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65575736 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59660966 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.58737399 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.55436416 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55062273 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50562482 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40938966 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.40299735 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.39920126 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30986819 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30661984 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29276651 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28180974 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24501733 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23337090 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22878034 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22662536 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20349971 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13836771 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12003438 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.09791213 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07046490 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03844377 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01647089 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98461242 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93401459 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93372244 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.89067050 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87353117 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81496627 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.80817640 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78623125 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77783402 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77731252 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75792446 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74231266 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70222734 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66692632 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63583846 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61211183 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61089308 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60894956 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59954077 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58533865 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57783095 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54875284 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50349187 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49289676 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46351152 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.46344677 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.45702101 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44698640 |
| 81 | Ribosome_Homo sapiens_hsa03010 | 0.44443959 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43149463 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42973439 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41352346 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41274117 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.38929401 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38822083 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35338488 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.34050004 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34026755 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33913473 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33664827 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32896826 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.32516425 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.32397558 |
| 96 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31355617 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30500395 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28695509 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28597484 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26682051 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26297044 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.25604196 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.23330995 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22826550 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.22570205 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.18926007 |
| 107 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.18875478 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18515603 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17053249 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.14225036 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13477267 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12770081 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12674570 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12144644 |
| 115 | Parkinsons disease_Homo sapiens_hsa05012 | 0.12022464 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.09609472 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.09559773 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.09312653 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.08909746 |

